as informed in foxnews
Zika virus mosquito possibly spreads dengue in same bite
Zika virus mosquito possibly spreads dengue in same bite
A single species of mosquito—Aedes aegypti—now spreads multiple virus/">virus/">virus/">virus/">virus/">virus/">virus/">virus/">viruses in the Western Hemisphere, including Zika, chikungunya, and dengue.That has prompted researchers to examine whether it may transmit more than one type of virus at once to people—and if so, what consequences that may have.In a new study presented Monday at the annual meeting of the American Society of Tropical Medicine & Hygiene, scientists from Colorado State University said they had evidence that Aedes aegypti mosquitoes could be infected with Zika and chikungunya simultaneously and could potentially transmit both viruses to humans in a single bite.
moreover from eurekalert
Human trials begin for Army-developed Zika purified inactivated virus (ZPIV) vaccine
Human trials begin for Army-developed Zika purified inactivated virus (ZPIV) vaccine
SILVER SPRING, Md.- The Walter Reed Army Institute of Research (WRAIR) began vaccinations today in a Phase 1 human clinical trial to test the safety and immunogenicity of the virus/">virus/">virus/">virus/">virus/">virus/">virus/">virus/">Zika purified inactivated virus (ZPIV) vaccine.Seventy-five healthy adults will be recruited to participate in the trial at WRAIR's Clinical Trial Center in Silver Spring, Md.
additionally fox2now
SLU to start Zika virus vaccine trial testing
SLU to start Zika virus vaccine trial testing
Please enable Javascript to watch this videoST. LOUIS, MO (KTVI) - Saint Louis University's vaccine center will soon begin a Phase 1 safety trial of a vaccine designed to prevent virus/">virus/">virus/">virus/">virus/">virus/">virus/">virus/">Zika virus infection, which can cause devastating birth defects and other health problems.Funded by the National Institutes of Health, SLU will test a vaccine candidate made from an inactive strain of the Zika virus to prevent infection.The investigation vaccine, called ZPIV, is being developed by the Walter Reed Army Institute of Research, in partnership with the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at HHS.
No comments:
Post a Comment